Flows rise into U.S. healthcare and tech funds in November By Reuters


© Reuters. A U.S flag is seen on the New York Stock Exchange in the Manhattan borough of New York City

(Reuters) – U.S. healthcare exchange traded funds (ETFs) have led inflows in November, bolstered by the progress in development of coronavirus vaccines.

Data from Morningstar showed U.S. healthcare ETFs have lured $1.7 billion in the first two weeks of this month after witnessing outflows in the past three months.

Graphic: Breakdown by sector for fund flows into U.S. equities – https://fingfx.thomsonreuters.com/gfx/mkt/gjnvwblkrpw/Breakdown%20by%20sector%20for%20funds’%20flows%20into%20U.S.%20equities.jpg

The news that Pfizer (N:) and German partner BioNTech SE’s (F:) experimental COVID-19 vaccine was more than 90% effective based on initial trial results lifted healthcare stocks last week.

However, increasing COVID-19 cases and proposals for new lockdowns in the United States have tempered some market optimism and prompted investors to look for safer stocks.

U.S tech stocks attracted $1.2 billion in the first two weeks of this month, as they have performed well during the period of previous economic shutdowns.

“With Covid-19 case counts rising sharply amid the cold weather, there is sentiment in some circles that economic activity in the near term could take a hit, especially with a new wave of shutdowns being proposed with each passing day,” said Jeff Weniger, director of asset allocation at WisdomTree Investments (NASDAQ:).

“Those concerns tend to witness capital flowing in the direction of tech stocks, which are the primary beneficiaries when the market is in a mood for a disinflationary and stagnant economic backdrop.”

Industrials, consumer discretionary and energy sectors also attracted inflows this month, data showed.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.





Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here